Health Care

Infographic: How Cipla performed in Q2 2022

● Dec 6, 2021

Cipla Limited(NSE: CIPLA) posted its second-quarter 2022 results. The company posted consolidated revenue of ₹5,580 crores with a growth of...

IPO Alert: API Holdings files DRHP with SEBI for public issue

● Nov 19, 2021

Healthcare spending in India grew at a healthy compound annual rate of 13% from 2015 to 2019 and reached around...

IOL Chemicals and Pharmaceuticals Ltd (IOLCP) Q2 FY22 Earnings Concall Transcript

● Nov 16, 2021

IOL Chemicals and Pharmaceuticals LTd (NSE:IOLCP) Q2 FY22 Earnings Concall dated Nov. 16, 2021 Corporate Participants: Monish Shah — Vice President,...

Krishna Institute of Medical Sciences Ltd (KIMS) Q2 FY22 Earnings Concall Transcript

● Nov 11, 2021

Krishna Institute of Medical Sciences Ltd (NSE:KIMS) Q2 FY22 Earnings Concall dated  Nov. 11, 2021, Corporate Participants: B. Bhaskar Rao...

Earnings: Aurobindo Pharma results in Q2 2022

● Nov 8, 2021

Aurobindo Pharma (NSE: AUROPHARMA) reported its second-quarter 2022 earnings results today. The company had a consolidated net profit of ₹696.71...

Divi’s Laboratories Ltd (DIVISLAB) Q2 FY22 Earnings Concall Transcript

● Nov 6, 2021

Divi’s Laboratories Ltd (NSE:DIVISLAB) Q2 FY22 Earnings Concall dated Nov. 06, 2021. Corporate Participants: M. Satish Choudhury — Company Secretary &...

Sun Pharmaceutical Industries Limited (SUNPHARMA) Q2 FY22 Earnings Concall Transcript

● Nov 5, 2021

Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA) Q2 FY22 Earnings Call dated Nov. 02, 2021 Corporate Participants: Nimish Desai — Head-Investor Relations Dilip...

Key highlights from Sun Pharma Q2 2022 earnings results

● Nov 2, 2021

Sun Pharmaceutical Industries (NSE: SUNPHARMA) reported its second-quarter 2022 earnings results today. The company reported consolidated revenue of ₹98.4 billion...

Cipla Ltd (CIPLA) Q2 FY22 Earnings Concall Transcript

● Nov 2, 2021

Cipla Limited (NSE: CIPLA) Q2 FY22 Earnings Concall dated Oct. 26, 2021 Corporate Participants: Naveen Bansal — Director, Finance Kedar Upadhye...

Key highlights from Dr Reddy’s Q2 2022 earnings results

● Oct 29, 2021

Dr Reddy’s Laboratories (NSE: DRREDDY) reported its second-quarter financial results for the period ended September 30, 2021. The company had...